definiens: Special Licensee No . 4Special Licenses " shall mean those lice nse agreements entered into between [COMPANY] and one or more Third Parties, as i dentified in a writing delivered by [COMPANY] to [COMPANY] with respect to this Secton 1.251 on the date of execution of this Agreement, which licenses are som etimes referred to herein individually as,, and ; provide d, however, that in no event shall any renewal, extension, revision, amendment o r other modification thereof entered into after the Effective Date, to the exten t that such renewal, extension, revision, amendment, or other modificati on provides to the Special Licensee any additional rights to access or use for research, development, or commercial purposes the [COMPANY] Mice, KM - Mice, the Ki rin Technology, or KM Patent Rights, be deemed to be a Special License for any p urpose under this Agreement ; provided, further, that for purposes of any payment obligations owed by [COMPANY] to [COMPANY] pursuant to Sections 10.2.2, 10.3.1(b ), an d 10.7.4 hereof, the special financial terms accorded to Special Licenses under such Sections shall be deemed not to apply to any renewal, extension, revision, a mendment or other modification made to a Special License at any time on or after December 27, 1999, to the extent that any such renewal, extensio n, revision, amendment, or other modification provides to the Special Licensee, in addition to the rights granted to the Special Licensee prior to such date, any rights to access or use for research, development and/or commercial purpose s any [COMPANY] Mice, KM Mice, [COMPANY] Technology or KM Patent Rights . By way of an example and without limitation, if [COMPANY] grants to a Special Licensee, pursuant to a Special License entered into prior to December 27, 1999, a right to obtain five ( 5 ) Antigen - exclusive commercial licenses under [COMPANY] T echnology and/or KM Patent Rights, and if any renewal, extension, revision, am endment or other modification to the applicable Special License on or after Decem ber 27, 1999, grants to the Special Licensee a right to obtain ten ( 10 ) Antigen -exclusive commercial licenses under such technology, for purposes of any payment obligation owed by [COMPANY] to [ * ]= Certain confidential information contained in t his document, marked by brackets, has been omitted and filed separately wit h the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended